4.7 Article

Masitinib Inhibits Hepatitis A Virus Replication

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Virology

Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication

Reina Sasaki-Tanaka et al.

Summary: This study identified nicotinamide as a potential therapeutic drug for HAV infection by inhibiting HAV replication through suppressing AP-1 activity and HAV IRES-mediated translation.

JOURNAL OF VIROLOGY (2023)

Article Biochemistry & Molecular Biology

Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking

Reina Sasaki-Tanaka et al.

Summary: Hepatitis A virus (HAV) infection is a major cause of acute hepatitis worldwide, and the prevalence of HAV vaccination is not adequate in some countries. The development of new anti-HAV therapeutic options has been motivated, and in silico and in vitro studies have identified potential inhibitors for HAV replication.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes

Reina Sasaki-Tanaka et al.

Summary: In this study, several novel therapeutic drugs were investigated through a drug repositioning approach, with favipiravir identified as a potential antiviral against hepatitis A virus (HAV) infection. The study examined the replication of HAV and introduced nucleotide mutations in the HAV genome using different drugs. Favipiravir showed inhibitory effects on HAV replication and introduced more nucleotide mutations compared to ribavirin. Further in vivo experiments are needed to confirm the efficacy of favipiravir in treating severe HAV infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

c-kit inhibitor masitinib induces reactive oxygen species-dependent apoptosis in c-kit-negative HepG2 cells

Yuta Semba et al.

Summary: Masitinib induces apoptosis in c-kit-negative HepG2 cells by targeting the redox balance through the JNK pathway, demonstrating its anticancer effects.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Virology

Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy

Reina Sasaki-Tanaka et al.

Summary: Amantadine and its derivative rimantadine effectively inhibit the replication of hepatitis A virus (HAV). Autophagy plays a significant role in HAV replication, and amantadine enhances autophagy to inhibit HAV replication.

JOURNAL OF VIROLOGY (2022)

Editorial Material Immunology

Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections

Tibor Bakacs et al.

FRONTIERS IN IMMUNOLOGY (2022)

Article Chemistry, Medicinal

In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease

Ulises Martinez-Ortega et al.

Summary: This study conducted molecular dynamics simulations of the interaction between masitinib (MST) and SARS-CoV-2 main protease (M-pro), identifying factors influencing the stability of the complex and providing valuable insights for the design of new MST analogs as potential treatments for COVID-19.

CHEMMEDCHEM (2021)

Article Multidisciplinary Sciences

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

Nir Drayman et al.

Summary: This study identified a drug called masitinib that can inhibit the replication of both SARS-CoV-2 and OC43 virus, and acts by competitively inhibiting 3CLpro. The drug showed strong antiviral effects in in vivo experiments on mice infected with SARS-CoV-2, and was effective against multiple variants in vitro.

SCIENCE (2021)

Article Gastroenterology & Hepatology

Changing Etiologies and Prognostic Factors in Pediatric Acute Liver Failure

Manuel Mendizabal et al.

LIVER TRANSPLANTATION (2020)

Article Public, Environmental & Occupational Health

Clinical trials on drug repositioning for COVID-19 treatment

Sandro G. Viveiros Rosa et al.

REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)

Article Biochemistry & Molecular Biology

Intravenous Delivery of piggyBac Transposons as a Useful Tool for Liver-Specific Gene-Switching

Shingo Nakamura et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Medicine, Research & Experimental

Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS

Emiliano Trias et al.

JCI INSIGHT (2018)

Article Medicine, Research & Experimental

Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS

Emiliano Trias et al.

JCI INSIGHT (2017)

Article Infectious Diseases

Hepatitis a virus genotypes and strains from an endemic area of Europe, Bulgaria 2012-2014

Roberto Bruni et al.

BMC INFECTIOUS DISEASES (2017)

Article Pharmacology & Pharmacy

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+T cells

Mercedes Bermejo et al.

BIOCHEMICAL PHARMACOLOGY (2016)

Article Pharmacology & Pharmacy

The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro

Veronique Descamps et al.

ANTIVIRAL RESEARCH (2015)

Article Biochemistry & Molecular Biology

The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells

Xia Jiang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity

Tatsuo Kanda et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Review Infectious Diseases

Hepatitis A: epidemiology in resource-poor countries

Rakesh Aggarwal et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2015)

Review Biotechnology & Applied Microbiology

piggyBac-ing models and new therapeutic strategries

Lauren E. Woodard et al.

TRENDS IN BIOTECHNOLOGY (2015)

Review Gastroenterology & Hepatology

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

Tatsuo Kanda et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)

Review Biochemistry & Molecular Biology

Possible Prognostic and Therapeutic Significance of c-Kit Expression, Mast Cell Count and Microvessel Density in Renal Cell Carcinoma

Ilaria Marech et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Biochemistry & Molecular Biology

A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1

Becky Pinjou Tsai et al.

OPEN BIOLOGY (2014)

Article Medicine, General & Internal

Acute liver failure

William Bernal et al.

LANCET (2010)

Article Immunology

Hepatitis A virus seroprevalence by age and world region, 1990 and 2005

Kathryn H. Jacobsen et al.

VACCINE (2010)

Article Gastroenterology & Hepatology

New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication

K. Himmelsbach et al.

Article Multidisciplinary Sciences

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

Patrice Dubreuil et al.

PLOS ONE (2009)

Article Food Science & Technology

Evaluation of an extracting method for the detection of Hepatitis A virus in shellfish by SYBR-Green real-time RT-PCR

Nerea Casas et al.

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2007)

Article Biochemistry & Molecular Biology

Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication

T Bürckstümmer et al.

FEBS LETTERS (2006)

Article Biochemistry & Molecular Biology

Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells

T Kanda et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Article Biotechnology & Applied Microbiology

Replication of a hepatitis A virus replicon detected by genetic recombination in vivo

V Gauss-Müller et al.

JOURNAL OF GENERAL VIROLOGY (2002)